Di Wang

Di Wang


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2022 in Cell & Bioscience
Verified
Journal Article
Open access
PDF file
XCXiufang Cui
Xiufang Cui
ZYZiping Ye
Ziping Ye
DWDi Wang
Di Wang
YYYan Yang
Yan Yang
CJChunHua Jiao
ChunHua Jiao
HZHongjie Zhang
Hongjie Zhang
Background: Intestinal immune dysfunction is involved in the onset of Crohn’s disease (CD). Dendritic cells (DCs), antigen-presenting cells, play a key role in the maintenance of intestinal immune homeostasis. The aryl hydrocarbon receptor (AhR) is a ligand-dependent transcription factor widely expressed in various immune cells, including DCs. Although AhR plays an important role in immune tolerance, its role in the DCs is unclear. The purpose of this study was to investigate whether the activation of AhR can induce tolerogenic DCs (tolDCs) and the differentiation of regulatory T (Treg) cells, as well as ameliorate experimental colitis. Results: AhR activation in the DCs resulted in a lower expression of surface markers such as CD80, CD83, CD86, and pro-inflammatory cytokine production, and higher anti-inflammatory production (IL-1β, IL-23, and IL-12) compared to the control DCs. The surface dendrites in DCs were significantly reduced following AhR activation by 6-formylindolo [3,2-b]carbazole (FICZ). Such DCs with FICZ-mediated activation of AhR, namely tolDCs, promoted Treg cell differentiation. Adoptive transfer of tolDCs to a TNBS-induced colitis mouse model significantly alleviated the severity of inflammation by improving the colon length and decreasing the disease activity index (DAI) and histopathological score. Moreover, the transferred tolDCs decreased the frequency of Th17 cells and increased the frequency of Treg cells in the spleen and mesenteric lymph nodes (MLNs) in murine colitis models. Conclusions: Activation of AhR in the DCs could induce tolDCs, and the transplantation of tolDCs may help in relieving intestinal inflammation and maintaining the Th17/Treg differentiation balance. Thus, our data suggest that AhR may be a potential therapeutic target for CD.

20 May 2025 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
LLLinzhen Li
Linzhen Li
THTulan Hu
Tulan Hu
DWDi Wang
Di Wang
Background and purpose: The specific pathogenesis of choledocholithiasis is still unclear. The objective of this study was to investigate whether serum cholesterol level is related to the incidence of choledocholithiasis.Patients and methods: A total of 169 choledocholithiasis patients were include in this study. We investigated whether total cholesterol (TC), triglyceride (TG), high density lipoprotein (HDL-C), low density lipoprotein (LDL-C), TC/TG, LDL-C/HDL-C in choledocholithiasis patients differed from that in healthy people.Results: There were 64 male and 105 female patients. There were significant differences in TC (P<0.001), TG (P=0.006), HDL-C (P<0.001) and LDL-C (P=0.001) between the two groups. The TC, TG, HDL-C, LDL-C in the choledocholithiasis patients group were significantly lower than that in the healthy population. In the subgroup analysis, we further investigate whether above parameters in choledocholithiasis patients differed from that in healthy people by gender. There was no significant difference in TG (P=0.182), TC/TG (P=0.982), LDL-C/HDL-C (P=0.392) between the male choledocholithiasis patients group and the male healthy population group. There were significant differences in TC (P=0.001), HDL-C (P=0.014) and LDL-C (P=0.026) between the two groups. There were no significant difference in TC/TG (P=0.590), LDL-C/HDL-C (P=0.116) between the female choledocholithiasis patients group and the female healthy population group. There were significant differences in TC (P<0.001), TG (P=0.016), HDL-C (P<0.001) and LDL-C (P=0.009) between the two groups.Conclusions: The serum TC, HDL-C and LDL-C in choledocholithiasis patients were significantly lower than those in healthy people.